355bitcoin.wiki • Professional Insights • Expert Commentary • Resource Center
355bitcoin.wiki

Top Alternatives,amino acid sequence

Unraveling the p53 Peptide Sequence: A Deep Dive into a Crucial Tumor Suppressor Aug 21, 2020—Tumor Protein P53 Peptide 1. Expand All - Collapse All. Antibodies Expressed Sequence: CALPNNTSSS(ph)PQPK. Native Sequence: Calculated 

:Acts as a tumor suppressor in many tumor types

A
Angela Ross

explores '' content strategies and effectiveness and provides detailed analysis through YouTube and Pinterest

Published on

Executive Summary

The nucleotide sequences of p53 gene are showed in below table Aug 21, 2020—Tumor Protein P53 Peptide 1. Expand All - Collapse All. Antibodies Expressed Sequence: CALPNNTSSS(ph)PQPK. Native Sequence: Calculated 

The p53 peptide sequence is a topic of significant interest in molecular biology and cancer research. The p53 protein, also known as TP53, is a critical tumor suppressor that plays a vital role in maintaining genomic stability. Its intricate sequence and function are central to understanding cellular responses to stress and the development of various diseases. This article will explore the p53 peptide sequence, its significance, and related aspects, drawing from extensive scientific data.

The TP53 gene encodes a protein with multiple functional domains, including transcriptional activation, DNA binding, and oligomerization domains. This protein acts as a transcription factor, binding to specific DNA sequences as a tetramer, a structure essential for its function. When cells encounter various stresses, such as DNA damage, oncogene activation, or hypoxia, p53 is activated and stabilized. This activation leads to the regulation of target genes that can induce cell cycle arrest, apoptosis (programmed cell death), senescence, or DNA repair, thereby preventing the proliferation of damaged or abnormal cells. Therefore, understanding the p53 sequence is fundamental to comprehending its multifaceted roles.

Specific fragments of the p53 protein, referred to as p53 peptides, have been synthesized and studied extensively. For instance, the amino acids 17 to 26 fragment of p53 is a well-characterized region known as the Mdm-2 binding domain. This domain is crucial for regulating p53 stability. The Mdm-2 protein targets p53 for degradation, and the binding of Mdm-2 to this peptide sequence is a key regulatory step. Research has focused on synthesizing peptides from this region, such as those spanning residues 12-26 (with the sequence PPLSQETFSDLWKLL) or residues 17-26, to investigate these interactions.

Another significant p53 peptide sequence is found in the C-terminal region. A synthetic peptide corresponding to the C-terminal region of human p53 has been utilized as an immunogen to generate antibodies for research applications, including ChIP assays. Similarly, a peptide designated p53 (232-240), representing a segment of the human tumor suppressor protein p53, has been shown to enhance its binding affinity.

The study of these p53 peptides extends to their potential therapeutic applications. For example, peptide sequences derived from p53 have been explored for their ability to bind and stabilize the p53 core domain, which is often mutated in cancers. One such peptide is CDB3, a nine-residue peptide that binds to and stabilizes the p53 core domain in vitro. Furthermore, peptide-analogue strategies have been employed to design molecules that mimic or enhance p53 function. The P4 peptide, for instance, shares key residues with the native p53 sequence and exhibits high affinity interactions.

The TP53 protein has a considerable length, with the Human TP53 coding and protein sequence containing numerous amino acids. Different isoforms and variants of p53 exist, adding complexity to its study. The Human p53 peptide can be derived from various regions, and researchers often focus on specific domains, such as the p53 tetramerization domain (TD), which is located between residues 324 and 356 in the sequence of human p53.

The TP53 gene is frequently altered in human cancers, making it a focal point of cancer research. Mutations in TP53 can lead to a loss of its tumor-suppressive function, promoting uncontrolled cell growth and tumor development. Identifying specific p53 peptide sequences recognized by immune cells, such as CD8+ T-cells, is an area of active research in cancer immunotherapy, aiming to develop targeted treatments.

In summary, the p53 peptide sequence is a rich area of scientific inquiry. From understanding the fundamental mechanisms of tumor suppression to developing novel therapeutic strategies, the detailed analysis of p53 fragments, including the amino acid sequence, Human p53 peptide, and p53 specific sequence variations, provides invaluable insights into cellular health and disease. The nucleotide sequences of p53 gene are also critical for understanding its genetic basis and the impact of mutations. The TP53 Database and NCBI resources offer comprehensive information on these sequences, facilitating further research into this vital tumor suppressor protein. Numerous synthetic peptides and pools of peptides are available for research, allowing scientists to probe the intricate functions of p53. The p53 protein's role in regulating cell cycle progression and apoptosis underscores the importance of studying its precise peptide sequences.

Related Articles

Frequently Asked Questions

Here are the most common questions about .

Trp53 transformation related protein 53 [ (house mouse)]
by N Rasafar·2020·Cited by 17—Alongside small molecules, some leadpeptide sequenceshave also been developed, mostly by the alteration in thep53-MDM2/X binding site ( 
PepMix Human (P53) Overlapping Peptide Pool
Peptides from the amino terminal mdm-2-binding domain of

Leave a Comment

Share your thoughts, feedback, or additional insights on this topic.

Explore More